Brokerages Set Corcept Therapeutics Incorporated (NASDAQ:COR

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) has earned an average recommendation of “Hold” from the seven analysts that are covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month price target among brokerages that […]

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , United States , New York , Sean Maduck , Piper Sandler , Joseph Douglas Lyon , Securities Exchange Commission , Corcept Therapeutics Incorporated , Nasdaq , Cambridge Investment Research Advisors Inc , Commonwealth Equity Services , Fintrust Capital Advisors , Linden Thomas Advisory Services , Get Free Report , Corcept Therapeutics , Exchange Commission , Douglas Lyon , York State Teachers Retirement System , Trust Capital Advisors , Investment Research Advisors , Equity Services , Thomas Advisory Services , Get Free , Therapeutics Incorporated , Corcept Therapeutics Daily , Nasdaq Cort , Cort , Medical , 21835210 , Ratings , Consensus ,